Literature DB >> 7235944

Intractable ascites treated with peritoneovenous shunts (LeVeen). A 24- to 64-month follow-up of results in 52 alcoholic cirrhotics.

H B Greenlee, M M Stanley, G F Reinhardt.   

Abstract

Peritoneovenous shunts (LeVeen) were placed in 52 patients with intractable ascites due to alcoholic cirrhosis between March 1975 and June 1978. The ascites was defined as intractable if it persisted despite at least six weeks of in-hospital medical management. Only 4.5% of such patients seen during this interval met this criterion by failing to respond to intensive drug and diet therapy. Eight (15%) died five to 60 days postoperatively; six of these did not undergo diuresis. Hepatic encephalopathy and sepsis were important contributing factors. There were 21 late deaths (mean survival, 16 months), primarily related to complications characteristic of this group of cirrhotics: upper gastrointestinal hemorrhage and infection. Twenty-three patients were alive by June 25, 1980, with mean survival of 46 months. Four patients operated on five or more years ago survive without ascites. An accurately placed LeVeen shunt dramatically relieves intractable ascites with improvement in renal function, nutrition, and general health. The operation enables at least partial rehabilitation so that ambulatory care becomes feasible for many of these chronically and seriously disabled patients.

Entities:  

Mesh:

Year:  1981        PMID: 7235944     DOI: 10.1001/archsurg.1981.01380170016003

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  10 in total

1.  Nonbacterial thrombotic endocarditis associated with the use of a peritoneovenous shunt.

Authors:  M Kaplansky; C V Reyes
Journal:  Tex Heart Inst J       Date:  1987-06

2.  Effect of peritoneo-venous shunt on portal pressure.

Authors:  A K Samanta; C M Leevy
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

Review 3.  [Peritoneovenous shunt in the treatment of therapy-refractory ascites].

Authors:  C A Eriksen; A Cuschieri
Journal:  Langenbecks Arch Chir       Date:  1988

4.  Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations.

Authors:  M M Stanley; C V Reyes; H B Greenlee; B Nemchausky; G F Reinhardt
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

5.  The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.

Authors:  C Smadja; D Franco
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

6.  Peritoneovenous shunt therapy for leaking ascites in the cirrhotic patient.

Authors:  M O'Connor; J I Allen; M L Schwartz
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

7.  Herniorrhaphy and concomitant peritoneovenous shunting in cirrhotic patients with umbilical hernia.

Authors:  J Belghiti; F Desgrandchamps; O Farges; F Fékété
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

8.  Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes.

Authors:  K Akimaru; Y Ueda; T Shoji
Journal:  Jpn J Surg       Date:  1988-09

9.  Palliation of malignant ascites by the Denver peritoneovenous shunt.

Authors:  R Downing; J Black; C W Windsor
Journal:  Ann R Coll Surg Engl       Date:  1984-09       Impact factor: 1.891

10.  Peritoneovenous shunting in intractable ascites.

Authors:  G T Deans; R A Spence; G W Johnston
Journal:  Ulster Med J       Date:  1985-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.